VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

RHUMBLINE ADVISERS's Holding History (CIK: 0001115418)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 104,721 Value ($000) $1,176 Avg Close — Range —
Q1 2025
Shares 103,707 Value ($000) $474 Avg Close — Range —
Q4 2024
Shares 111,203 Value ($000) $627 Avg Close — Range —
Q3 2024
Shares 109,110 Value ($000) $528 Avg Close — Range —
Q2 2024
Shares 112,446 Value ($000) $549 Avg Close — Range —
Q1 2024
Shares 100,247 Value ($000) $1,331 Avg Close — Range —
Q4 2023
Shares 81,200 Value ($000) $1,132 Avg Close — Range —
Q3 2023
Shares 79,602 Value ($000) $1,056 Avg Close — Range —
Q2 2023
Shares 79,383 Value ($000) $1,488 Avg Close — Range —
Q1 2023
Shares 71,794 Value ($000) $1 Avg Close — Range —
Q4 2022
Shares 67,933 Value ($000) $1 Avg Close — Range —
Q3 2022
Shares 64,067 Value ($000) $2,201 Avg Close — Range —
Q2 2022
Shares 50,763 Value ($000) $776 Avg Close — Range —
Q1 2022
Shares 36,980 Value ($000) $844 Avg Close — Range —
Q4 2021
Shares 17,824 Value ($000) $657 Avg Close — Range —
Q3 2021
Shares 17,640 Value ($000) $829 Avg Close — Range —